Hao Gao | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Prof. Hao Gao | Healthcare Data Analysis | Best Researcher Award

Jinan University, China

Author Profiles

orcid

Scopus

Research Gate

👨‍🎓 Early Academic Pursuits

Prof. Hao Gao began his academic journey with a strong foundation in natural medicine chemistry. He received his PhD from Shenyang Pharmaceutical University in 2005, focusing on the chemistry of natural medicines. This early academic work set the stage for his future contributions to the field of Traditional Chinese Medicine (TCM). After completing his doctorate, he further honed his expertise through postdoctoral training at Tsinghua University (2006-2008), a renowned institution that significantly influenced his approach to scientific research and innovation.

💼 Professional Endeavors and Leadership

Prof. Gao’s professional trajectory has been marked by leadership roles that have shaped his career and the direction of his research. In 2008, he joined the Institute of Traditional Chinese Medicine & Natural Products at Jinan University as a faculty member. Since 2013, he has been a professor at the university and, in 2016, assumed the position of Head of the Institute of Traditional Chinese Medicine & Natural Products. In 2020, he expanded his administrative responsibilities by taking on the role of Director of the Science and Technology Department at Jinan University. Prof. Gao’s leadership has been pivotal in fostering multidisciplinary collaborations and advancing research initiatives in natural medicine chemistry.

🔬 Contributions and Research Focus

Prof. Gao’s research is primarily centered on natural medicine chemistry, with a particular focus on the active compounds and technological advancements related to Traditional Chinese Medicine (TCM). His work is dedicated to exploring under-researched medicinal materials like Lycium barbarum, Angelica sinensis, and Ophiocordyceps sinensis, which are central to TCM practices. Prof. Gao has made significant strides in identifying bioactive substances and developing novel drugs derived from TCM. Notably, his research has led to the discovery of four classes of lead compounds for anti-dementia drugs, all characterized by independent intellectual property rights.

🌍 Impact and Influence

Prof. Gao’s impact extends beyond academia, with substantial contributions to the modernization of TCM and drug development. His collaborations with international experts, such as Professor Ikuro Abe from the University of Tokyo, have facilitated the establishment of the International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, a joint initiative between China’s Ministry of Education and Jinan University. This partnership exemplifies Prof. Gao’s influence on global TCM research and highlights his role in pushing the boundaries of natural product-based drug development.

📚 Academic Citations and Recognition

Prof. Gao’s research has gained widespread recognition, reflected in his 4100 citations across various SCI journals. His work has significantly contributed to the advancement of natural medicine chemistry and TCM, making him a highly influential figure in the field. His numerous publications, with 195 journal articles and one book published, continue to shape research in TCM and pharmacology. Moreover, his leadership as an editor for the China Section of the Journal of Natural Medicines and as an editorial board member for Acta Pharmaceutica Sinica B highlights his prominence in the academic community.

🛠️ Technical Skills and Innovations

Prof. Gao’s technical expertise spans various critical areas, including the extraction, isolation, and characterization of bioactive compounds from TCM. His innovations in pharmacodynamic constituents of TCM have contributed to the discovery of novel drug candidates, some of which are in the process of patenting. With over 71 patents published or pending, Prof. Gao stands at the forefront of translating TCM practices into scientifically validated therapeutic solutions. His lab continues to focus on critical technologies that aim to enhance the efficacy and safety of TCM-derived medicines.

👩‍🏫 Teaching Experience

In addition to his research, Prof. Gao has been an integral part of the academic community at Jinan University, mentoring and guiding students in the fields of pharmacology and natural medicine chemistry. His teaching philosophy integrates cutting-edge research with practical applications in TCM, ensuring that his students are well-equipped to pursue careers in both academia and industry. As a mentor, Prof. Gao has inspired numerous graduate students and postdoctoral researchers, many of whom have gone on to make their own contributions to TCM and drug development.

🌱 Legacy and Future Contributions

Prof. Gao’s legacy is built on his pioneering work in natural medicine chemistry and the modernization of Traditional Chinese Medicine. His research continues to influence the field, with ongoing projects that promise to uncover more bioactive compounds and therapeutic agents. As his career progresses, Prof. Gao remains committed to advancing TCM through innovation and interdisciplinary collaboration. His future work will likely expand the global recognition of TCM-based drugs, pushing the boundaries of natural product drug discovery and pharmacology for the betterment of human health.

🌟 Professional Memberships and Editorial Roles

Prof. Gao is an active member of the China Association of Chinese Medicine, where he serves as Vice Chairperson of the Youth Work Committee. His role in professional societies and editorial boards, including his editorial positions in high-impact journals, underscores his authority in the fields of natural products and biosynthesis. His leadership extends to guiding the next generation of researchers and practitioners in these fields.

📖 Top Noted Publications 

Functional and structural dissection of glycosyltransferases underlying the glycodiversity of wolfberry-derived bioactive ingredients lycibarbarspermidines
    • Authors: Li, S.-Y., Wang, G.-Q., Long, L., Abe, I., Gao, H.
    • Journal: Nature Communications
    • Year: 2024
Identification of three novel P450 enzymes involved in the oxidative modification of a newly discovered fusicoccane diterpene
    • Authors: Dong, L., Liu, J.-Y., Wang, G.-Q., Hu, D., Gao, H.
    • Journal: Bioorganic Chemistry
    • Year: 2024
Targeted Discovery of a Natural ortho-Quinone Methide Precursor and Green Generation of Its Oligomers
    • Authors: Wang, X.-X., Deng, B.-Q., Ouyang, Z.-Q., Yao, X.-S., Gao, H.
    • Journal: Journal of Natural Products
    • Year: 2024
A Functional Switch Between Asperfumene and Fusicoccadiene Synthase and Entrance to Asperfumene Biosynthesis through a Vicinal Deprotonation-Reprotonation Process
    • Authors: Liu, J.-Y., Lin, F.-L., Taizoumbe, K.A., Gao, H., Dickschat, J.S.
    • Journal: Angewandte Chemie – International Edition
    • Year: 2024
Mechanistic characterisation of a fungal fusicoccane-type diterpene synthase involved in the biosynthesis of talaro-7,13-diene
    • Authors: Lin, F.-L., Taizoumbe, K.A., Wang, Y.-X., Gao, H., Dickschat, J.S.
    • Journal: Organic and Biomolecular Chemistry
    • Year: 2024

Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Posted on by ScienceFather

Dr. Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Institut Pasteur Algérie, Algeria

Author Profile

🎓 Early Academic Pursuits

Dr. Tahar Kernif’s academic journey began in 2004 when he completed his Doctorate in Veterinary Science at the École Nationale Vétérinaire d’Alger, where he conducted a comparative study on treatments for canine Leishmaniasis. This research laid the foundation for his future work in veterinary parasitology. Dr. Kernif then pursued a Magistère in Parasitology at the same institution, focusing on zoonotic diseases and vectors, which further honed his expertise in vector-borne infections. These early academic achievements earned him distinction and sparked his lifelong commitment to studying infectious diseases.

🧑‍🔬 Professional Endeavors

Since 2013, Dr. Kernif has been a Maître de Recherche at the Institut Pasteur d’Alger, where he works on molecular techniques to study parasitic diseases in veterinary science. His research focuses on Protozoa, Helminths, and the molecular ecology of arthropod vectors. He has played an integral role in shaping the institute’s research activities on infectious diseases and environmental health, contributing to key initiatives in the field of veterinary parasitology. Dr. Kernif’s professional work is also marked by collaborations with international research institutions such as CIRAD and IRD, where he has worked on studying arthropod microbiota through meta-proteomics.

🔬 Contributions and Research Focus

Dr. Kernif’s primary research interests lie in Infectious Diseases and Health and Environment, specifically focusing on multi-omics approaches to understanding pathogen behavior. His work spans genomics, metagenomics, and proteomics, applying these techniques to study diseases like leishmaniasis and tick-borne infections. His research includes phylogenetic analysis and bioinformatic modeling, which have contributed significantly to the molecular understanding of parasite-host interactions, providing insights into disease transmission and control strategies.

🌍 Impact and Influence

Dr. Kernif’s contributions extend beyond research, as he is actively involved in national health policy and scientific review boards. He served as associate editor for New Microbes and New Infections and has been a scientific examiner for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). His work has shaped policies related to biodiversity and environmental health, especially in Algeria, where he is part of the National Expert Working Group for the Libreville Declaration on Health and Environment. His influence on public health and policy is a testament to his broad impact in both scientific and governmental circles.

📚 Academic Cites

Dr. Kernif has authored 35 international publications and contributed to two book chapters, demonstrating his prominent role in infectious disease research. His studies are frequently cited in scientific journals, reflecting his influence in veterinary parasitology and zoonotic diseases. His work in molecular epidemiology and vector-borne pathogens has made a lasting impact on the field and continues to guide contemporary research.

🛠️ Technical Skills

Dr. Kernif is highly proficient in a range of advanced techniques critical to research in parasitology and microbiology. His expertise spans capillary sequencing, next-generation sequencing (NGS), and PCR/qPCR, which are essential for molecular surveillance and unraveling genetic information. He is also skilled in MALDI-TOF Mass Spectrometry, currently in progress, allowing for detailed molecular analysis of pathogens. Additionally, Dr. Kernif utilizes bioinformatics to analyze complex datasets, helping to interpret vast amounts of biological data. His proficiency in meta-proteomics is instrumental in studying the microbiota of arthropods, providing insights into disease mechanisms and transmission. These tools equip Dr. Kernif with the ability to conduct precise and impactful research, advancing our understanding of infectious diseases.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Kernif has shared his expertise through academic mentorship and scientific training. As a researcher at the Institut Pasteur d’Alger, he supervises graduate students and engages in international collaborations to promote knowledge exchange. His teaching and mentorship in the field of veterinary parasitology and infectious diseases continue to shape the next generation of scientists.

🌱 Legacy and Future Contributions

Dr. Kernif’s legacy is marked by his scientific publications, international collaborations, and his influence in shaping research policy in infectious diseases. Moving forward, his research is poised to address emerging health threats, particularly those arising from vector-borne diseases. His continued contributions to global health initiatives and his work on disease surveillance are expected to leave a lasting mark on the fields of veterinary entomology and infectious disease control.

 

📖 Top Noted Publications

Update on tick-borne rickettsioses around the world: a geographic approach
    • Authors: P Parola, CD Paddock, C Socolovschi, MB Labruna, O Medianikov, …
    • Journal: Clinical Microbiology Reviews
    • Year: 2013
Borrelia, Rickettsia, and Ehrlichia species in bat ticks, France, 2010
    • Authors: C Socolovschi, T Kernif, D Raoult, P Parola
    • Journal: Emerging Infectious Diseases
    • Year: 2012
Matrix-assisted laser desorption ionization–time of flight mass spectrometry for rapid identification of tick vectors
    • Authors: A Yssouf, C Flaudrops, R Drali, T Kernif, C Socolovschi, JM Berenger, …
    • Journal: Journal of Clinical Microbiology
    • Year: 2013
Identification of flea species using MALDI-TOF/MS
    • Authors: A Yssouf, C Socolovschi, H Leulmi, T Kernif, I Bitam, G Audoly, L Almeras, …
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2014
Rickettsiae of spotted fever group, Borrelia valaisiana, and Coxiella burnetii in ticks on passerine birds and mammals from the Camargue in the south of France
    • Authors: C Socolovschi, P Reynaud, T Kernif, D Raoult, P Parola
    • Journal: Ticks and Tick-Borne Diseases
    • Year: 2012

Fatemeh Shah-Mohammadi | Clinical Data Science | Best Researcher Award

Posted on by ScienceFather

Dr. Fatemeh Shah-Mohammadi | Clinical Data Science | Best Researcher Award

Dr. Fatemeh Shah-Mohammadi at University of Utah, United States

 Professional Profiles👨‍🎓

 Early Academic Pursuits 🎓

Dr. Fatemeh Shah-Mohammadi completed her Master of Science in Electrical and Communication Engineering at Birjand University of Technology, where she laid the groundwork for her expertise in engineering and technology. She then pursued her PhD at Rochester Institute of Technology, specializing in Machine Learning. Her dissertation focused on “Machine Learning-enabled Resource Allocation in Underlay Cognitive Radio Networks,” demonstrating her commitment to applying advanced technologies in innovative ways.

Professional Endeavors 💼

Dr. Shah-Mohammadi currently serves as a Research Assistant Professor of Biomedical Informatics at the University of Utah, where she applies her skills in health informatics and clinical data science. Her professional journey includes significant roles as a Biostatistician II/NLP Engineer at Mount Sinai Health System and a postdoctoral fellow at the Icahn School of Medicine. These experiences have equipped her with a robust foundation in data analysis and machine learning applications across diverse domains.

Contributions and Research Focus 🔍

Dr. Shah-Mohammadi’s research primarily centers on the intersection of health informatics and machine learning. She has developed machine learning models that leverage cross-domain datasets to improve clinical outcomes. Notable projects include NLP-assisted pipelines for clinical note analysis and differential diagnosis, highlighting her dedication to enhancing healthcare delivery through technology.

Impact and Influence 🌍

Dr. Shah-Mohammadi’s work has significant implications for health informatics, particularly in the use of natural language processing (NLP) for clinical applications. Her publications in respected journals, such as the IEEE Open Journal of the Communications Society and Studies in Health Technology and Informatics, showcase her contributions to advancing knowledge in this field. Her research efforts aim to reduce diagnostic uncertainty and improve patient care outcomes, underscoring her influence in biomedical informatics.

Academic Cites 📚

Dr. Shah-Mohammadi’s scholarly output includes multiple peer-reviewed articles that have garnered citations and recognition within the academic community. Her ORCID and Google Scholar profiles further highlight her impact, showcasing a growing body of work that contributes to the fields of health informatics and machine learning.

Technical Skills 🛠️

Dr. Shah-Mohammadi is proficient in various technical areas, including:

  • Machine Learning and Data Science
  • Natural Language Processing
  • Statistical Analysis
  • Software Development for Biomedical Applications Her expertise enables her to build and implement sophisticated models that address real-world clinical challenges.

Teaching Experience 👩‍🏫

As an instructor at the University of Utah, Dr. Shah-Mohammadi teaches courses like “Generative AI in Healthcare” and “Intro to Programming.” Her teaching philosophy emphasizes the integration of cutting-edge technology with foundational principles, preparing students for future challenges in biomedical informatics.

Grants and Funding 💰

Dr. Shah-Mohammadi has actively sought and secured funding for her research initiatives. As the Principal Investigator for a project on automated live meta-analysis of clinical outcomes using generative AI, she demonstrates leadership in advancing research in health informatics. Her involvement as a co-investigator in various projects further highlights her collaborative spirit and dedication to impactful research.

Legacy and Future Contributions 🌟

Looking ahead, Dr. Shah-Mohammadi aims to continue her work at the forefront of health informatics, leveraging machine learning and NLP to drive innovations in clinical practice. Her commitment to research, teaching, and community engagement positions her as a leading figure in the field, poised to make lasting contributions to both academia and healthcare.

📖 Top Noted Publications 

 Addressing Semantic Variability in Clinical Outcome Reporting Using Large Language Models

Authors: Fatemeh Shah-Mohammadi, Joseph Finkelstein
Journal: BioMedInformatics
Year: 2024

 Extraction of Substance Use Information From Clinical Notes: Generative Pretrained Transformer–Based Investigation

Authors: Fatemeh Shah-Mohammadi, Joseph Finkelstein
Journal: JMIR Medical Informatics
Year: 2024

Accuracy Evaluation of GPT-Assisted Differential Diagnosis in Emergency Department

Authors: Fatemeh Shah-Mohammadi, Joseph Finkelstein
Journal: Diagnostics
Year: 2024

Neural Network Cognitive Engine for Autonomous and Distributed Underlay Dynamic Spectrum Access

Authors: Fatemeh Shah-Mohammadi, Hatem Hussein Enaami, Andres Kwasinski
Journal: IEEE Open Journal of the Communications Society
Year: 2021

 NLP-Assisted Differential Diagnosis of Chronic Obstructive Pulmonary Disease Exacerbation

Authors: Fatemeh Shah-Mohammadi, Joseph Finkelstein
Journal: Studies in Health Technology and Informatics
Year: 2024

Using Electronic Medical Records and Clinical Notes to Predict the Outcome of Opioid Treatment Program

Authors: W Cui, Fatemeh Shah-Mohammadi, Joseph Finkelstein
Journal: Healthcare Transformation with Informatics and Artificial Intelligence
Year: 2023

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Posted on by ScienceFather

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

👨‍🎓 Professional Profile

🎓 Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

🏢 Professional Endeavors

Dr. Vaughan’s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for women’s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

🌟 Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

🌍 Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

📚 Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

🔧 Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

🏅 Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

📖 Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021